Ghent University Academic Bibliography

Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach

Barbara Depreter (UGent) , Barbara De Moerloose (UGent) , Karl Vandepoele (UGent) , Anne Uyttebroeck, An Van Damme, Eva Terras (UGent) , Barbara Denys (UGent) , Laurence Dedeken, Marie-Francoise Dresse, Jutte Van der Werff Ten Bosch, et al.

(2021) PEDIATRIC RESEARCH.

Add to list

Use of chimerism analysis after allogeneic stem cell transplantation : Belgian guidelines and review of the current literature

Anke Delie (UGent) , Anke Verlinden, Karolien Beel, Dries Deeren, Dominiek Mazure (UGent) , Frederic Baron, Dimitri Breems, Ann De Becker, Carlos Graux, Philippe Lewalle, et al.

(2021) ACTA CLINICA BELGICA.

Add to list

Sepsis and septic shock in patients with malignancies : a Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique study

Virginie Lemiale, Stéphanie Pons, Adrien Mirouse, Jean-Jacques Tudesq, Yannick Hourmant, Djamel Mokart, Frédéric Pène, Achille Kouatchet, Julien Mayaux, Martine Nyunga, et al.

(2020) CRITICAL CARE MEDICINE. 48(6). p.822-829

Add to list

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

G. J. Ossenkoppele, D. A. Breems, G. Stuessi, Y. Van Norden, M. Bargetzi, B. J. Biemond, P. A von dem Borne, Y. Chalandon, J. Cloos, D. Deeren, et al.

(2020) LEUKEMIA. 34(7). p.1751-1759

Add to list

Journal Article
A1
open access

How to make an immune system and a foreign host quickly cohabit in peace? The challenge of acute graft-versus-host disease prevention after allogeneic hematopoietic cell transplantation

Benoit Vandenhove, Lorenzo Canti, Helene Schoemans, Yves Beguin, Frederic Baron, Carlos Graux, Tessa Kerre (UGent) and Sophie Servais

(2020) FRONTIERS IN IMMUNOLOGY. 11.

Add to list

Journal Article
A1
open access

Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI

Arnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, Riitta Niittyvuopio, Johan Maertens, Xavier Poire, Jan Cornelissen, Peter Remenyi, Jean Henri Bourhis, Yves Beguin, et al.

(2019) BLOOD ADVANCES. 3(13). p.1950-1960

Add to list

Journal Article
A1
open access

Physiological expression of miR-130a during differentiation of CD34+ human hematopoietic stem cells results in the inhibition of monocyte differentiation

Fabiana Mammoli, Sandra Parenti, Mariana Lomiento, Claudia Gemelli, Claudio Giacinto Atene, Alexis Grande, Roberto Corradini, Alex Manicardi (UGent) , Sebastian Fantini, Tommaso Zanocco-Marani, et al.

(2019) EXPERIMENTAL CELL RESEARCH. 382(1).

Add to list

Clinical implications of measurable residual disease in AML : review of current evidence

Ine Moors (UGent) , Karl Vandepoele (UGent) , Jan Philippé (UGent) , Dries Deeren, Dominik Selleslag, Dimitri Breems, Nicole Straetmans, Tessa Kerre (UGent) and Barbara Denys (UGent)

(2019) CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY. 133. p.142-148

Add to list

Journal Article
A1
open access

Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies

Tim Pieters (UGent) , Sara T'Sas (UGent) , Lisa Demoen (UGent) , André Pedro Pinto De Almeida (UGent) , Lieven Haenebalcke (UGent) , Filip Matthijssens (UGent) , Kelly Lemeire (UGent) , Jinke D'Hont (UGent) , Frédérique Vanrockeghem (UGent) , Tino Hochepied (UGent) , et al.

(2019) SCIENTIFIC REPORTS. 9.

Add to list

Journal Article
A1
open access

Phase I dose‐escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors

François Doz, Franco Locatelli, André Baruchel, Nicolas Blin, Barbara De Moerloose (UGent) , Didier Frappaz, Michael Dworzak, Matthias Fischer, Jan Stary, Rene Fuertig, et al.

(2019) PEDIATRIC BLOOD & CANCER. 66(10).

Academic Bibliography

Deciphering molecular heterogeneity in pediatric AML using a cancer vs. normal transcriptomic approach

Use of chimerism analysis after allogeneic stem cell transplantation : Belgian guidelines and review of the current literature

Sepsis and septic shock in patients with malignancies : a Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique study

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

How to make an immune system and a foreign host quickly cohabit in peace? The challenge of acute graft-versus-host disease prevention after allogeneic hematopoietic cell transplantation

Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI

Physiological expression of miR-130a during differentiation of CD34+ human hematopoietic stem cells results in the inhibition of monocyte differentiation

Clinical implications of measurable residual disease in AML : review of current evidence

Novel strategy for rapid functional in vivo validation of oncogenic drivers in haematological malignancies

Phase I dose‐escalation study of volasertib in pediatric patients with acute leukemia or advanced solid tumors

Contents

Support

Contact